# Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy

Study · id `cardio:ct-nct01572129` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01572129](<https://clinicaltrials.gov/study/NCT01572129>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01572129

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

## Technical summary

Registry record NCT01572129. Randomized; double masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2012-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT01572129, source copy `cardio:ctgov-nct01572129-2012-04-06`, retrieved 2026-10-26)
- Start date: 2011-11 (registry gives no type) (ClinicalTrials.gov record NCT01572129, source copy `cardio:ctgov-nct01572129-2012-04-06`, retrieved 2026-10-26)
- Primary completion: 2012-05 (anticipated) (ClinicalTrials.gov record NCT01572129, source copy `cardio:ctgov-nct01572129-2012-04-06`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Italy (ClinicalTrials.gov record NCT01572129, source copy `cardio:ctgov-nct01572129-2012-04-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01572129-2012-04-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
- Condition: Acute Coronary Syndrome
- Condition: Myocardial Infarction
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Placebo
- Lead sponsor: Campus Bio-Medico University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Campus Bio-Medico University (`cardio:org-campus-bio-medico-university`)

## Provenance

Content hash: e7af1f949acb1af98b97fb92a67fb9ca67bcc29bb80156e7c6bb6bbc5eb73906
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
